TrialSignal transduction and targeted therapy2024

Sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in extensive-stage small cell lung cancer: a phase II clinical trial.

Xiao Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.